We are working together to identify early non-invasive biomarkers that signal deteriorations in the brain so that we can help people in Israel, America and all over the world.
BOCA RATON, Fla. (PRWEB) December 05, 2017
Dr. Ygal Rotenstreich, Director of the Retinal Research Laboratory at Sheba Medical Center’s Goldschleger Eye Institute and Director of its Electrophysiology and Hereditary Retinal Diseases Clinic, showcased his groundbreaking research at an “Imagination Israel” event that took place November 30. Dr. Rotenstreich was among a group of leading Israeli entrepreneurs who spoke about Israel’s culture of innovation and their cutting-edge products and companies. The Jewish Community Relations Council of the Jewish Federation of South Palm Beach County hosted the series of presentations.
More than 700 people were in attendance as Dr. Ygal Rotenstreich presented a revolutionary medical device he invented, which uses advanced noninvasive, objective testing to detect early signs of eye and Alzheimer’s Disease. His team’s findings could lead to much earlier identification in patients, allowing them to take preventative action sooner than ever before.
In his remarks, the Israeli medical entrepreneur talked about how the eye is a window into the brain and discussed his current research at Sheba Medical Center. Over 450 clinical trials for Alzheimer’s Disease treatment failed because the intervention was too late, a key problem that Dr. Rotenstreich’s device addresses.
Sheba Medical Center is the largest and most comprehensive medical center in the entire Middle East. With 20 percent of Israel’s population visiting for treatment each year, the hospital provides for the healthcare needs of the nation while fostering life-saving medical innovation, the impact of which is felt around the world.
Dr. Rotenstreich presented his device alongside four other Israeli success stories: Voiceitt, Zeekit, TaKaDu and Tridom Robotics. All of these high-tech innovators contribute to Israel’s unique standing in the world as the “Start-up Nation.”
“The culture of innovation at Sheba and the collaboration between leading Israeli researchers and our partners in the United States has been crucial in bringing this idea to market,” said Dr. Rotenstreich. “We are working together to identify early non-invasive biomarkers that signal deteriorations in the brain so that we can help people in Israel, America and all over the world.”
Following the presentation, dozens of attendees remained outside the auditorium to speak with Dr. Rotenstreich and to ask him questions about his research and the medical technology device he expects to be available in 2018.
About Sheba Medical Center
Born together with Israel in 1948, Sheba Medical Center, Tel Hashomer is the largest and most comprehensive medical center in the Middle East. Sheba is the only medical center in Israel that combines an acute care hospital and a rehabilitation hospital on one campus, and it is at the forefront of medical treatments, patient care, research and education. As a university teaching hospital affiliated with the Sackler School of Medicine at Tel-Aviv University, it welcomes people from all over the world indiscriminately.